Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300436 Fujian Cosunter Pharmaceutical
- 30.05
- +0.66+2.25%
Market Closed Apr 30 15:00 CST
4.79BMarket Cap-28.14P/E (TTM)
30.20High29.39Low19.97KlotVolume29.39Open29.39Pre Close59.84MTurnover1.46%Turnover RatioLossP/E (Static)159.27MShares41.2052wk High14.43P/B4.11BFloat Cap14.1652wk Low35.27Limit Up136.72MShs Float166.92Historical High23.51Limit Down2.76%Amplitude12.28Historical Low--Dividend TTM29.96Avg Price8.85KlotAsk--Div YieldTTM100Lot Size10.69KlotBid
About Fujian Cosunter Pharmaceutical Company
The company was founded in June 2001 and successfully listed on the Shenzhen Stock Exchange on April 22, 2015. The company is a national high-tech enterprise and a national intellectual property demonstration enterprise. It has various provincial technology innovation platforms such as the National Enterprise Technology Center and the Fujian Key Laboratory for Liver Disease. Adhering to the corporate mission of “broadcasting benevolence and focusing on people's livelihood”, the company firmly believes in the dream of providing scientific solutions for human liver health, unswervingly promotes innovative drug research and development, implements innovative development strategies, and is committed to fighting the coronavirus, hepatitis B, liver cancer, and liver fibrosis, creating innovative drugs belonging to the Chinese people, and contributing core strength to the innovation and development of independent and controllable drugs in China. The company's main products: anti-hepatitis B virus drugs, hepatoprotective drugs, men's health drugs, cardiovascular drugs, etc. Corporate honors: China Patent Excellence Award; High-tech Enterprise Certificate; Second Prize of Fujian Patent Award; Third Prize of Fujian Science and Technology Progress Award, etc.
Company Profile
Short Name-A广生堂
Symbol-A300436
Company NameFujian Cosunter Pharmaceutical Co.,Ltd.
Listing DateApr 22, 2015
Issue Price21.47
Shares Offered17.50M share(s)
FoundedJun 28, 2001
Legal Representativeguoping li
General Managerguoping li
Secretaryqinghe zhang
Accounting FirmBeijing Dehao International Accounting Firm (Special General Partnership)
Securities Representativedanqing chen
Legal CounselGuo Hao Law Firm (Shanghai)
Employees298
Phone0591-38265188
Office AddressBuilding 16, Haixi Hi-Tech Industrial Park Innovation Park Phase II, No. 7, Wulongjiang Middle Avenue, Fuzhou High-tech Zone, Minhou County, Fuzhou City, Fujian Province
Zip Code350108
Registered AddressBuilding 1-7, Fuyuan Industrial Park, Zherong County, Ningde City, Fujian Province
Fax0591-83052199
Emailzhangqinghe@cosunter.com
Websitehttp://www.cosunter.com/
Business License350926100003095
BusinessLicense items: pharmaceutical production; pharmaceutical wholesale; pharmaceutical retail; food sales; food production; health food production; pharmaceutical import and export; pharmaceutical internet information service. (Projects requiring approval according to law can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by relevant departments) General projects: medical research and experimental development; health food (pre-packaged) sales; technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; technology import and export; import and export of goods. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with law)
Company Executives
- Name
- Position
- Salary
- guoping li
- Chairman, Directors, General Manager, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee
- 1.20M
- liqing ye
- Directors, Audit Committee Member
- --
- chenming zhuang
- Directors, Deputy General Manager
- 783.30K
- guodong li
- Directors, Strategy Committee Member, Nomination Committee Members, Audit Committee Member
- 421.20K
- fuhu huang
- Directors, Chief Operating Officer, Strategy Committee Member
- 2.35M
- hongjun wu
- Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee
- 60.00K
- feimei wu
- Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Member
- 60.00K
- fengmin lu
- Independent Directors, Audit Committee Member, Chairman of the Nomination Committee, Strategy Committee Member
- 60.00K
- qinghe zhang
- Board Secretary, Deputy General Manager
- 471.10K
- danqing chen
- Securities Affairs Representative
- --
- baoming shi
- Chairman of the Supervisory Board, Auditors
- --
- houlin xiao
- Auditors
- 26.00K
- bingxiang ceng
- Deputy General Manager
- 616.50K
- yanru hu
- Deputy General Manager
- --
- jianhui guan
- Chief Financial Officer
- 795.80K
- meixiang lu
- Head of Internal Audit
- --
- weizhong mao
- Chief Scientist, Chief Development Officer
- 900.00K
- ke hu
- Chief Scientist
- --
- haifeng lin
- Employee Supervisors
- 301.50K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts